Corrigendum to "Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7" [Biochim. Biophys. Acta 1859(5) (2017) 835-844].

The authors would like to correct Fig. 4. The electrostatic surface potential maps of HwTx-IV and gHWTx-IV are not correctly represented in the published Fig. 4B. Please find below the correct Fig. 4. [Formula presented] Although the electrostatic maps were not correct, they did not affect the discussion of the results and the conclusions. The paragraph referring to the Figure in the manuscript is correct: “Furthermore, a global profile of the electrostatic surface potential on the surface of gHwTx-IV containing the four mutations (E1G, E4G, F6W and Y33W) is more positive than the same surface on HwTx-IV (Fig. 4B), and gHwTx-IV has a higher net charge and residual dipole moment than HwTx-IV (Table 3)”. The authors would like to apologize for any inconvenience caused.